Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
36
IPHA Quote, Financials, Valuation and Earnings
Last price:
$2.10
Seasonality move
:
-9.3%
Day range:
$2.06 - $2.21
52-week range:
$1.29 - $3.51
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.11x
P/B ratio:
21.96x
Volume:
8.1K
Avg. volume:
27.5K
1-year change:
-20.36%
Market cap:
$201.8M
Revenue:
$13.7M
EPS (TTM):
-$0.45
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $64.1M | $14.3M | $52.3M | $56.2M | $13.7M | |
| Revenue Growth (YoY) | -16.5% | -77.66% | 264.92% | 7.46% | -75.69% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $56.8M | $55.6M | $54.5M | $60.6M | $56.3M | |
| Selling, General & Admin | $14.5M | $18.9M | $15.3M | $12.7M | $12.9M | |
| Other Inc / (Exp) | -$2.4M | $2.8M | -$44.1M | $2.8M | $251.1K | |
| Operating Expenses | $62.9M | $70.9M | $69.6M | $69.9M | $69.5M | |
| Operating Income | $1.2M | -$56.6M | -$17.3M | -$13.7M | -$55.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$946.7K | -$53.8M | -$61.1M | -$8.2M | -$53.5M | |
| Earnings of Discontinued Ops. | -$72.1M | -$8.7M | -$138.2K | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$73.1M | -$62.5M | -$61.3M | -$8.2M | -$53.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$73.1M | -$62.5M | -$61.3M | -$8.2M | -$53.5M | |
| Basic EPS (Cont. Ops) | -$0.93 | -$0.78 | -$0.77 | -$0.10 | -$0.66 | |
| Diluted EPS (Cont. Ops) | -$0.93 | -$0.78 | -$0.77 | -$0.10 | -$0.66 | |
| Weighted Average Basic Share | $78.9M | $79.5M | $79.6M | $80.5M | $81.1M | |
| Weighted Average Diluted Share | $78.9M | $79.5M | $79.6M | $80.5M | $81.1M | |
| EBITDA | $64.3M | -$48M | -$12.9M | -$2M | -$50.8M | |
| EBIT | -$557.3K | -$53.4M | -$60.8M | -$7.5M | -$52.9M | |
| Revenue (Reported) | $64.1M | $14.3M | $52.3M | $56.2M | $13.7M | |
| Operating Income (Reported) | $1.2M | -$56.6M | -$17.3M | -$13.7M | -$55.8M | |
| Operating Income (Adjusted) | -$557.3K | -$53.4M | -$60.8M | -$7.5M | -$52.9M | |
| Period Ending | 2017-04-30 | 2018-04-30 | 2019-04-30 | 2020-04-30 | 2021-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $239.9M | $262.4M | $261.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $155.3M | $163.7M | $160.4M | |
| Gross Profit | -- | -- | $84.6M | $98.7M | $100.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $50.8M | $52.3M | $49.3M | |
| Other Inc / (Exp) | -- | -- | $666K | $975K | -$90K | |
| Operating Expenses | -- | -- | $50.8M | $52.3M | $49.3M | |
| Operating Income | -- | -- | $33.8M | $46.3M | $51.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | $34.6M | $47.3M | $51.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $8.4M | $11.1M | $12.2M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $26.1M | $36.2M | $39.1M | |
| Basic EPS (Cont. Ops) | -- | -- | $0.28 | $0.38 | $0.42 | |
| Diluted EPS (Cont. Ops) | -- | -- | $0.28 | $0.38 | $0.42 | |
| Weighted Average Basic Share | -- | -- | $93.3M | $93.2M | $93.3M | |
| Weighted Average Diluted Share | -- | -- | $93.8M | $93.5M | $93.6M | |
| EBITDA | -- | -- | $34.4M | $55.1M | $59M | |
| EBIT | -- | -- | $30.5M | $46.3M | $51.4M | |
| Revenue (Reported) | -- | -- | $239.9M | $262.4M | $261.1M | |
| Operating Income (Reported) | -- | -- | $33.8M | $46.3M | $51.4M | |
| Operating Income (Adjusted) | -- | -- | $30.5M | $46.3M | $51.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $64.2M | $14.4M | $52.5M | $56.4M | $13.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $56.4M | $55.1M | $53.9M | $60.8M | $55.7M | |
| Selling, General & Admin | $14.2M | $19.1M | $15.3M | $12.8M | $12.8M | |
| Other Inc / (Exp) | -$2.4M | $2.8M | -- | -- | -- | |
| Operating Expenses | $62.1M | $70.2M | $68.9M | $70M | $68.8M | |
| Operating Income | $2.1M | -$55.9M | -$16.4M | -$13.6M | -$55.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$48.2K | -$53.1M | -$59M | -$8.1M | -$53M | |
| Earnings of Discontinued Ops. | -- | -$8.8M | -$137.1K | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$75.3M | -$61.9M | -$59.1M | -$8.1M | -$53M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$75.3M | -$61.9M | -$59.1M | -$8.1M | -$53M | |
| Basic EPS (Cont. Ops) | -$0.95 | -$0.77 | -$0.74 | -$0.10 | -$0.65 | |
| Diluted EPS (Cont. Ops) | -$0.95 | -$0.77 | -$0.74 | -$0.10 | -$0.65 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $67.5M | -$47.3M | -$11.9M | -$1.9M | -$50.2M | |
| EBIT | $342.6K | -$52.7M | -$58.4M | -$7.4M | -$52.4M | |
| Revenue (Reported) | $64.2M | $14.4M | $52.5M | $56.4M | $13.5M | |
| Operating Income (Reported) | $2.1M | -$55.9M | -$16.4M | -$13.6M | -$55.3M | |
| Operating Income (Adjusted) | $342.6K | -$52.7M | -$58.4M | -$7.4M | -$52.4M | |
| Period Ending | 2021-06-01 | 2022-06-01 | 2023-06-01 | 2024-06-01 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $168.2M | $117.5M | $90.3M | $78M | $69.1M | |
| Short Term Investments | $18.3M | $18.2M | $18.5M | $24.2M | $15M | |
| Accounts Receivable, Net | $13M | $957.9K | $3.3M | $16.8M | $676.4K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $9.8M | $5.6M | $7.9M | $10M | $3.5M | |
| Other Current Assets | -- | $1.1K | $2.2K | $1.1K | -- | |
| Total Current Assets | $213.3M | $156.5M | $150M | $163.6M | $89.2M | |
| Property Plant And Equipment | $14.4M | $11.5M | $9.2M | $7M | $5.3M | |
| Long-Term Investments | $47.9M | $45.2M | $37.7M | $10.8M | $10.7M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $56.9M | $50M | $1.7M | $459.9K | -- | |
| Other Long-Term Assets | $182K | $169.8K | $163K | $96.2K | $598.3K | |
| Total Assets | $378.1M | $302.9M | $213.7M | $193.7M | $115.6M | |
| Accounts Payable | $25.5M | $16.7M | $14.6M | $9.5M | $8.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.7M | $33.9M | $1.4M | $9.3M | $8.8M | |
| Current Portion Of Capital Lease Obligations | $955.7K | $910.3K | $883.7K | $536.1K | $282K | |
| Other Current Liabilities | $2.3M | $8.4M | $11M | $8.5M | $7.7M | |
| Total Current Liabilities | $55.9M | $90.4M | $44.3M | $43.8M | $34.3M | |
| Long-Term Debt | $17.5M | $13M | $41.7M | $33.8M | $23.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $186.3M | $181.2M | $155.7M | $136.3M | $106.4M | |
| Common Stock | $4.9M | $4.5M | $4.3M | $4.5M | $4.4M | |
| Other Common Equity Adj | $436.6K | $516.3K | $878.3K | $547.2K | $28.1K | |
| Common Equity | $191.8M | $121.6M | $58.1M | $57.4M | $9.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $191.8M | $121.6M | $58.1M | $57.4M | $9.2M | |
| Total Liabilities and Equity | $378.1M | $302.9M | $213.7M | $193.7M | $115.6M | |
| Cash and Short Terms | $186.5M | $135.7M | $108.8M | $102.2M | $84M | |
| Total Debt | $19.1M | $46.9M | $43.1M | $43.2M | $31.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $168.2M | $117.5M | $90.3M | $78M | $69.1M | |
| Short Term Investments | $18.3M | $18.2M | $18.5M | $24.2M | $15M | |
| Accounts Receivable, Net | $13M | $957.9K | $3.3M | $16.8M | $676.4K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $9.8M | $5.6M | $7.9M | $10M | $3.5M | |
| Other Current Assets | -- | $1.1K | $2.2K | $1.1K | -- | |
| Total Current Assets | $213.3M | $156.5M | $150M | $163.6M | $89.2M | |
| Property Plant And Equipment | $14.4M | $11.5M | $9.2M | $7M | $5.3M | |
| Long-Term Investments | $47.9M | $45.2M | $37.7M | $10.8M | $10.7M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $56.9M | $50M | $1.7M | $459.9K | -- | |
| Other Long-Term Assets | $182K | $169.8K | $163K | $96.2K | $598.3K | |
| Total Assets | $378.1M | $302.9M | $213.7M | $193.7M | $115.6M | |
| Accounts Payable | $25.5M | $16.7M | $14.6M | $9.5M | $8.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.7M | $33.9M | $1.4M | $9.3M | $8.8M | |
| Current Portion Of Capital Lease Obligations | $955.7K | $910.3K | $883.7K | $536.1K | $282K | |
| Other Current Liabilities | $2.3M | $8.4M | $11M | $8.5M | $7.7M | |
| Total Current Liabilities | $55.9M | $90.4M | $44.3M | $43.8M | $34.3M | |
| Long-Term Debt | $17.5M | $13M | $41.7M | $33.8M | $23.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $186.3M | $181.2M | $155.7M | $136.3M | $106.4M | |
| Common Stock | $4.9M | $4.5M | $4.3M | $4.5M | $4.4M | |
| Other Common Equity Adj | $436.6K | $516.3K | $878.3K | $547.2K | $28.1K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $191.8M | $121.6M | $58.1M | $57.4M | $9.2M | |
| Total Liabilities and Equity | $378.1M | $302.9M | $213.7M | $193.7M | $115.6M | |
| Cash and Short Terms | $186.5M | $135.7M | $108.8M | $102.2M | $84M | |
| Total Debt | $19.1M | $46.9M | $43.1M | $43.2M | $31.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$73.1M | -$62.5M | -$61.3M | -$8.2M | -$53.5M | |
| Depreciation & Amoritzation | $64.9M | $5.4M | $47.9M | $5.5M | $2.2M | |
| Stock-Based Compensation | $2.8M | $3.1M | $4.5M | $4.6M | $4.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$59.1M | -$69.2M | -$20.2M | -$35.2M | -$7.5M | |
| Capital Expenditures | $12.9M | $1.6M | $1.2M | $2.5M | $423.2K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$15.3M | -$1.1M | $2M | $22.3M | $10M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.6M | $34M | -- | -- | -- | |
| Long-Term Debt Repaid | -$2.6M | -$2.4M | -$2.1M | -$2.6M | -$9.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $1.1K | $1.2K | -- | -- | -- | |
| Cash From Financing | -$1.3M | $31.7M | -$1.9M | -$2.1M | -$6.5M | |
| Beginning Cash (CF) | $231.7M | $161.8M | $109.4M | $91.2M | $76.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$75.7M | -$38.5M | -$20.1M | -$15M | -$4M | |
| Ending Cash (CF) | $156.2M | $122.8M | $88.8M | $76.4M | $71.9M | |
| Levered Free Cash Flow | -$72M | -$70.7M | -$21.4M | -$37.8M | -$7.9M | |
| Period Ending | 2017-03-31 | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $2.2B | $22.5B | $4B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | $17.3M | $5B | $14.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | $63.9M | $492.2M | -$789K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$75.3M | -$61.9M | -$59.1M | -$8.1M | -$53M | |
| Depreciation & Amoritzation | $67.1M | $5.4M | $46.5M | $5.5M | $2.1M | |
| Stock-Based Compensation | $2.9M | $3M | $4.5M | $4.6M | $4.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$56.4M | -$68.8M | -$19.5M | -$35.2M | -$7.3M | |
| Capital Expenditures | $12.6M | $1.5M | $1.2M | $2.5M | $419.8K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$14.8M | -$1.1M | $1.9M | $22.2M | $9.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$2.6M | -$2.4M | -$2.1M | -$2.6M | -$9.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$1.3M | $30.6M | -$1.9M | -$2.1M | -$6.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$72.3M | -$39.6M | -$19.3M | -$15M | -$4.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$69M | -$70.3M | -$20.7M | -$37.8M | -$7.7M | |
| Period Ending | 2021-06-01 | 2022-06-01 | 2023-06-01 | 2024-06-01 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get IPHA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IPHA
Sector
P/E ratio
--
24.37x
PEG ratio
0.03x
0.00x
P/B ratio
21.96x
1.74x
Price / LTM sales
13.11x
1.65x
Growth Metrics
IPHA
Sector
Revenue growth
--
5.12%
Earnings growth
--
7.46%
Revenue (5-year growth)
-29.2%
8.25%
Earnings forecast
--
-$0.20
Profitability
IPHA
Sector
Profitability FY 2025
--
$51.2M
Return on invested capital
-39.78%
-14.95%
Return on assets
-18.89%
-12.07%
Return on equity
-72.79%
-17.16%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Sep
17
Estimated Next Earnings Date
Aug
12
Balance Sheet
IPHA
Sector
Total cash
$98.4M
$38.3M
Short term investments
$15M
$33.2M
Total assets
$115.6M
$118.2M
Long term debt
$38.1M
$8.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
